All stocks today
71229 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

The Medicines Company revenue reports

The Medicines Company financial reports, The Medicines Company annual revenue in 2024. When does The Medicines Company report revenue?
Add to widgets
Added to widgets

The Medicines Company total revenue, net income and dynamics of changes in US dollar today

The Medicines Company current income and income for the latest reporting periods. Net revenue of The Medicines Company on 31/03/2019 amounted to 0 $. Net income The Medicines Company - -59 865 000 $. Information about net income is used from open sources. The financial schedule of The Medicines Company consists of three charts of the main financial indicators of the company: total assets, net revenue, net income. The Medicines Company net income is shown in blue on the graph. The value of The Medicines Company assets on the online chart is displayed in green bars.

Report date Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2019 0 $ -100 % ↓ -59 865 000 $ -305.376 % ↓
31/12/2018 0 $ - -42 474 000 $ -
30/09/2018 -3 300 000 $ -119.56 % ↓ -55 634 000 $ -
30/06/2018 1 667 000 $ -91.106 % ↓ -54 197 000 $ -
31/03/2018 7 771 000 $ - 29 149 000 $ -
31/12/2017 -15 040 000 $ - -178 260 000 $ -
30/09/2017 16 871 000 $ - -30 175 000 $ -
30/06/2017 18 742 000 $ - -397 268 000 $ -
Show:
to

The Medicines Company financial report charts

The dates of the latest financial statements of The Medicines Company: 30/06/2017, 31/12/2018, 31/03/2019. The dates of financial statements are strictly regulated by law and financial statements. The latest financial report of The Medicines Company is available online for such a date - 31/03/2019. Operating income The Medicines Company is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income The Medicines Company is -43 993 000 $

The Medicines Company quarterly report dates

Net income The Medicines Company is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income The Medicines Company is -59 865 000 $ Current assets The Medicines Company is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets The Medicines Company is 258 099 000 $ Total assets The Medicines Company refers to the total amount of assets owned by a person or entity. Total assets The Medicines Company is 835 853 000 $

Current cash The Medicines Company - the sum of all of the cash a company has on the date of report. Current cash The Medicines Company is 199 736 000 $ Current debt The Medicines Company is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital. Current debt The Medicines Company is 63 145 000 $ Total debt The Medicines Company is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year. Total debt The Medicines Company is 911 242 000 $

31/03/2019 31/12/2018 30/09/2018 30/06/2018 31/03/2018 31/12/2017 30/09/2017 30/06/2017
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
- -697 000 $ -4 190 000 $ -964 000 $ 5 034 000 $ -22 797 000 $ 7 270 000 $ 2 460 000 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
- 697 000 $ 890 000 $ 2 631 000 $ 2 737 000 $ 7 757 000 $ 9 601 000 $ 16 282 000 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
- - -3 300 000 $ 1 667 000 $ 7 771 000 $ -15 040 000 $ 16 871 000 $ 18 742 000 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
- - -3 300 000 $ 1 667 000 $ 7 771 000 $ -15 040 000 $ 16 871 000 $ 18 742 000 $
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-43 993 000 $ -25 576 000 $ -43 752 000 $ -46 467 000 $ -64 283 000 $ -16 075 000 $ -85 766 000 $ -80 212 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-59 865 000 $ -42 474 000 $ -55 634 000 $ -54 197 000 $ 29 149 000 $ -178 260 000 $ -30 175 000 $ -397 268 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
27 011 000 $ 29 711 000 $ 32 736 000 $ 26 994 000 $ 40 366 000 $ 21 033 000 $ 45 838 000 $ 33 072 000 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
43 993 000 $ 25 576 000 $ 40 452 000 $ 48 134 000 $ 69 317 000 $ -6 722 000 $ 93 036 000 $ 82 672 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
258 099 000 $ 294 803 000 $ 187 249 000 $ 219 046 000 $ 283 071 000 $ 563 304 000 $ 297 838 000 $ 436 028 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
835 853 000 $ 841 686 000 $ 733 737 000 $ 795 837 000 $ 861 174 000 $ 872 983 000 $ 1 006 980 000 $ 1 151 109 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
199 736 000 $ 238 310 000 $ 118 708 000 $ 162 530 000 $ 221 505 000 $ 151 359 000 $ 166 734 000 $ 202 422 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
63 145 000 $ 58 411 000 $ 77 757 000 $ 84 417 000 $ 655 943 000 $ 649 198 000 $ - 330 637 000 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
- - - - 240 483 000 $ 151 359 000 $ 208 902 000 $ 333 967 000 $
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
911 242 000 $ 863 950 000 $ 760 301 000 $ 774 608 000 $ 1 311 886 000 $ 1 298 396 000 $ - 636 154 000 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
109.02 % 102.65 % 103.62 % 97.33 % 152.34 % 148.73 % - 55.26 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
-75 389 000 $ -22 264 000 $ -26 564 000 $ 21 229 000 $ 67 656 000 $ 24 914 000 $ 188 055 000 $ 142 953 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-49 823 000 $ -39 027 000 $ -57 427 000 $ -56 020 000 $ -109 321 000 $ -63 514 000 $ -129 422 000 $ -55 750 000 $

Last revenue report of The Medicines Company was 31/03/2019. According to last financial report total revenue in The Medicines Company was 0 US dollar and changed by -100% since last year. Net income in The Medicines Company was -59 865 000 $ in last quartal, net income changes to -305.376%.

Cash flow The Medicines Company is the net amount of cash and cash-equivalents being transferred into and out of a business. Cash flow The Medicines Company is -49 823 000 $

The Medicines Company stocks data

The Medicines Company financials